Samenvatting
Treatment for cancer has improved in the last decades, resulting in a significantly reduced morbidity and mortality. 1-3 Unfortunately, many systemic treatment options are associated with an increased risk of adverse cardiac effects. 4 These adverse cardiac effects have given rise to the field of cardiooncology. This review summarizes recent findings related to the pathophysiology and treatment of drug-induced cardiac dysfunction in cancer treatment and looks ahead at new developments in the field.
Originele taal-2 | English |
---|---|
Pagina's (van-tot) | 481-490 |
Aantal pagina's | 10 |
Tijdschrift | Clinical Pharmacology & Therapeutics |
Volume | 101 |
Vroegere onlinedatum | 10-jan.-2017 |
DOI's | |
Status | Published - apr.-2017 |